Lilly’s Zepbound Cut Risk of Diabetes by 94% in Obese People
Bloomberg Businessweek
00:00
Exploring Weight Loss Drugs and Their Long-Term Health Implications
This chapter explores the impacts of weight loss medications on health, focusing on type 2 diabetes and obesity-related conditions. It considers recent findings on their effectiveness, the implications of long-term use, and the interplay of economic factors and treatment combinations for optimal patient outcomes.
Transcript
Play full episode
